10-QPeriod: Q1 FY1997

BOSTON SCIENTIFIC CORP Quarterly Report for Q1 Ended Mar 31, 1997

Filed May 15, 1997For Securities:BSX

Summary

Boston Scientific Corporation's (BSX) 10-Q filing for the period ending March 30, 1997, indicates a company in an active growth and development phase. While specific financial figures like revenue, net income, or detailed balance sheet items are not directly provided in this excerpt, the filing is essential for investors tracking the company's operational status and regulatory compliance during that period. The document's existence confirms ongoing reporting to the SEC, a fundamental aspect of investor confidence and transparency. Investors should note that this filing is from 1997, a period predating many of the company's major product launches and acquisitions that shaped its current market position. Therefore, insights derived solely from this document would offer a historical perspective on BSX's foundational operations and its commitment to financial disclosure in the late 1990s, rather than reflecting its present-day performance or strategic direction.

Key Highlights

  • 1The filing represents Boston Scientific Corp's (BSX) Quarterly Report (10-Q) for the period ending March 30, 1997.
  • 2The report was officially filed with the SEC on May 14, 1997.
  • 3This filing is part of BSX's ongoing commitment to regulatory compliance and financial transparency with its investors.
  • 4The document is hosted on the SEC's EDGAR database, accessible for public review.
  • 5The provided excerpt is a directory listing, indicating the structure and availability of the full filing documents.
  • 6Investors can access the full 10-Q report and related documents through the EDGAR system for detailed financial and operational information.
  • 7This filing provides a snapshot of the company's financial status and disclosures from the first quarter of 1997.

Frequently Asked Questions

This 10-Q filing is a mandatory quarterly report that Boston Scientific Corporation submits to the U.S. Securities and Exchange Commission (SEC). Its purpose is to provide investors and the public with an update on the company's financial performance and operational status during the specified fiscal quarter, ensuring transparency and regulatory compliance.

The provided text is a directory listing of the filing documents. To access detailed financial statements (like the balance sheet, income statement, and cash flow statement), you would need to locate and download the full report, typically available in .txt or HTML format, from the SEC's EDGAR database using the provided filing details.

This filing is from March 1997. While it provides accurate historical financial information for that period, it does not reflect Boston Scientific's current business operations, financial performance, or strategic direction, which have evolved significantly since then. Investors seeking information on the company's present state should consult more recent filings.

The filing date indicates when Boston Scientific officially submitted the report to the SEC. This date is important for understanding the timeline of financial disclosures and for investors tracking the timeliness of the company's reporting obligations.